Holy Stone Healthcare Co (ROCO:4194) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4194 Holy Stone Healthcare Co Ltd ROCO:4194
19 GF Score
Price NT$6.28
! 2 Warning Signs
View Full Analysis

What is Holy Stone Healthcare Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

ROCO:4194
19GF Score
Holy Stone Healthcare Co Ltd ROCO:4194
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Holy Stone Healthcare Co Business Description

Address Number 88, Section 1, Neihu Road, 4th Floor, Neihu District, Taipei, TWN, 11493
Holy Stone Healthcare Co Ltd is a Taiwan based company focused on a biopolymer drug delivery platform. It is involved in the development of new drugs and medical devices, especially hyaluronic acid related therapeutic products. The products of the company include RenehaVis, SportVis, TRUD, and GAF.
19GF Score

Get the complete analysis for ROCO:4194

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$6.28
Price